Loading...
XTAI
1701
Market cap196mUSD
Aug 20, Last price  
21.15TWD
Name

China Chemical & Pharmaceutical Co Ltd

Chart & Performance

D1W1MN
XTAI:1701 chart
P/E
19.56
P/S
0.74
EPS
1.08
Div Yield, %
Shrs. gr., 5y
0.09%
Rev. gr., 5y
2.50%
Revenues
8.57b
+1.40%
4,353,831,0004,555,141,0005,024,675,0004,947,571,0005,173,846,0005,297,426,0005,627,644,0005,781,413,0006,244,807,0007,580,236,0007,969,700,0008,181,056,0007,948,998,0008,456,512,0008,574,720,000
Net income
322m
-32.51%
387,913,000358,416,000305,904,000322,118,000240,347,000347,723,000353,696,000313,209,000310,739,000369,870,000384,690,000557,365,000517,508,000477,541,000322,294,000
CFO
239m
+43.10%
447,612,000377,266,000114,851,000365,259,000402,583,000330,409,000554,847,000194,220,000462,305,000152,926,000327,513,000897,071,000695,891,000167,272,000239,365,000
Dividend
Jul 26, 20240.50003 TWD/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

China Chemical & Pharmaceutical Co., Ltd. (CCP), established in Taipei, Taiwan, in 1952, is a prominent player in the pharmaceutical sector. The company specializes in the research, development, manufacturing, and distribution of generic pharmaceutical and healthcare products, serving both human and animal health markets. Its extensive human pharmaceutical portfolio encompasses a wide array of therapeutic areas. Key offerings include medications for cardiovascular health (such as treatments for heart conditions, cholesterol management, and peripheral circulation disorders), metabolic conditions (including diabetes, weight management, and corticosteroid therapies), and infectious diseases (like antibiotics, antifungals, and antivirals). CCP also provides a range of nutritional supplements, from vitamins and hepatic support agents to electrolyte and caloric preparations. Other significant categories cover pain and inflammation relief (antipyretics, analgesics, anti-inflammatories), digestive system remedies (gastrointestinal drugs, gut health enhancers, antispasmodics), and respiratory treatments (antitussives, antihistamines, and asthma medications). Furthermore, the company produces drugs addressing urological issues (specifically for benign prostatic hyperplasia), central nervous system disorders (hypnotics, mood stabilizers, and antidepressants), and critical areas like hematology and oncology, alongside other general preparations and sexual well-being products. Beyond prescription medications, CCP's non-prescription (OTC) division offers popular consumer health products, such as vitamins, topical skincare items, cold and cough remedies, anti-inflammatory pain relievers, and digestive aids. The company additionally supplies antibacterial and disinfectant solutions. In the animal health sector, CCP manufactures veterinary pharmaceuticals catering to livestock (pigs and cattle), poultry, and companion animals, alongside various feed supplements. Rounding out its operations, China Chemical & Pharmaceutical Co., Ltd. offers contract manufacturing services to other industry players.
IPO date
Feb 09, 1962
Employees
Domiciled in
TW
Incorporated in
TW

Valuation

Title
TWD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT